The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering, and broader global regenerative medicine sector trends and metrics in the first quarter of 2019.

By further curating information provided by ARM’s data partner Informa, the quarterly data report details industry-specific statistics compiled from 917 cell therapy, gene therapy, tissue engineering, and other regenerative medicine therapeutic developers worldwide, including total financings, partnerships and other deals, clinical trial information, key clinical data events, and ARM’s current strategic priorities.

Amanda Micklus, a senior consultant for Pharma Intelligence at Informa, provided an overview of the commercial, clinical, and regulatory environment in the first quarter of 2019. The report also features commentary from ARM’s 2019 Cell and Gene Investor Day. Investors and therapeutic developers weighed in on key issues in the sector, including the investment landscape, challenges in manufacturing at scale, and the outlook for these therapies over the next five to 10 years.

Highlighted findings from the Q1 2019 data report include:

• Globally, companies active in gene and cell therapies and other regenerative medicines raised more than $2.2 billion in the first quarter of 2019. The report also includes financial data broken out by technology type and financing type.
• There were 1,060 clinical trials underway worldwide at the close of the first quarter of 2019, with more than 58% of those in oncology and 8% in cardiovascular disorders. The report also includes figures on clinical trials by phase and indication, as well as by technology type.

ARM will continue to update this information through new reports to be released after the close of each quarter, tracking sector performance, key financial information, clinical trials by phase, and significant clinical data events.

The report is available online here, with interactive data and downloadable graphics from the report available here.